ストックスクリーナーアプリを入手
1.77
0.57%
0.01
アフターアワーズ：
1.75
-0.02
-1.13%
前日終値:
$1.76
開ける：
$1.81
24時間の取引高:
80,359
Relative Volume:
0.20
時価総額：
$6.37M
収益：
-
当期純損益:
$-15.47M
株価収益率:
-3.54
EPS:
-0.5
ネットキャッシュフロー:
$-13.51M
1週間 パフォーマンス:
-7.81%
1か月 パフォーマンス:
-17.67%
6か月 パフォーマンス:
+31.11%
1年 パフォーマンス:
-60.22%
1日の値動き範囲:
$1.7001
$1.8516
1週間の範囲:
$1.7001
$1.93
52週間の値動き範囲:
$1.30
$5.6432
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
NLSP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
1.77 | 7.48M | 0 | -15.47M | -13.51M | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nls Pharmaceutics Ltd (NLSP) 最新ニュース
Why NLS Pharmaceutics AG Equity Warrant stock is recommended by analystsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Regression analysis insights on NLS Pharmaceutics AG Equity Warrant performanceJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Combining machine learning predictions for NLS Pharmaceutics AGJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
What indicators show strength in NLS Pharmaceutics AG Equity WarrantJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock outperform value stocksDollar Strength & High Return Stock Watch Alerts - newser.com
Can a trend reversal in NLS Pharmaceutics AG lead to recoveryWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com
Is NLS Pharmaceutics AG a candidate for recovery playEarnings Overview Summary & Smart Money Movement Alerts - newser.com
Analyzing recovery setups for NLS Pharmaceutics AG Equity Warrant investors2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Will NLS Pharmaceutics AG Equity Warrant rebound enough to break evenGold Moves & Real-Time Stock Entry Alerts - newser.com
NLS Pharmaceutics files financial statements related to Kadimastem merger - Investing.com India
NLS Pharmaceutics Announces Strategic Merger with Kadimastem - TipRanks
NLS Pharmaceutics files financial statements related to Kadimastem merger By Investing.com - Investing.com UK
Will NLS Pharmaceutics AG Equity Warrant bounce back from current supportQuarterly Trade Report & Real-Time Volume Analysis Alerts - newser.com
What’s next for NLS Pharmaceutics AG Equity Warrant stock priceQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
What to expect from NLS Pharmaceutics AG Equity Warrant in the next 30 daysJuly 2025 Rallies & AI Driven Stock Reports - newser.com
How NLS Pharmaceutics AG stock reacts to Fed rate cutsJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Is NLS Pharmaceutics AG stock positioned well for digital economyWeekly Trend Recap & Technical Pattern Based Signals - newser.com
NLS Pharmaceutics AG Stock Analysis and ForecastPortfolio Risk Assessment & Identify Safe Investments - earlytimes.in
NLS Pharmaceutics Approve Merger with Kadimastem - citybiz
NLS Pharmaceutics stock tumbles after merger approval with Kadimastem By Investing.com - Investing.com Nigeria
NLS Pharmaceutics stock tumbles after merger approval with Kadimastem - Investing.com
NLSP Stock Faces Highs and Lows: A Closer Look - StocksToTrade
NLS Pharmaceutics Stock: What’s Next? - timothysykes.com
NLS Pharmaceutics shareholders approve merger with Kadimastem By Investing.com - Investing.com Australia
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem - TipRanks
NLS Pharmaceutics shareholders approve merger with Kadimastem - Investing.com India
NLS Pharmaceutics shareholders approve merger with Kadimastem and related proposals at extraordinary general meeting - MarketScreener
84.4% Ownership Stake: Kadimastem-NLS Pharma Merger Creates NewCelX with ALS and Diabetes Pipeline - Stock Titan
Is NLS Pharmaceutics AG stock dividend yield sustainableWeekly Risk Summary & High Yield Equity Trading Tips - newser.com
NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World
Visual trend scoring systems applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Using economic indicators to assess NLS Pharmaceutics AG Equity Warrant potentialWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Is NLS Pharmaceutics AG stock ready for a breakoutTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Market reaction to NLS Pharmaceutics AG Equity Warrant’s recent newsJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
Custom strategy builders for tracking NLS Pharmaceutics AGMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com
Rally Mode: Does NLS Pharmaceutics AG stock benefit from AI growthPrice Action & Low Risk Growth Stock Ideas - خودرو بانک
NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation - The Globe and Mail
What data driven models say about NLS Pharmaceutics AG Equity Warrant’s futureJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
What the charts say about NLS Pharmaceutics AG Equity Warrant todayNew Guidance & Free Accurate Trade Setup Notifications - newser.com
How moving averages guide NLS Pharmaceutics AG tradingTreasury Yields & High Accuracy Trade Signal Alerts - newser.com
Chart based exit strategy for NLS Pharmaceutics AGProfit Target & Intraday High Probability Setup Alerts - newser.com
Is NLS Pharmaceutics AG stock reversal real or fakeQuarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com
Nls Pharmaceutics Ltd (NLSP) 財務データ
収益
当期純利益
現金流量
EPS
1.11%
大文字化:
|
ボリューム (24 時間):